The prosurvival protein BAG3: a new participant in vascular homeostasis

Cell Death and Disease - Tập 7 Số 10 - Trang e2431-e2431
Albino Carrizzo1, Antonio Damato1, Mariateresa Ambrosio1, Antonia Falco2,3, Alessandra Rosati4,3, Mario Capunzo4, Michele Madonna1, Maria Caterina Turco4,3, James L. Januzzi5, Vincenzo De Laurenzi6,3, Carmine Vecchione4,1
1IRCCS Neuromed, Pozzilli (IS), Italy
2Department of Pharmacy, University of Salerno, Fisciano, SA, Italy
3Vascular Pathophysiology Unit, Biouniversa s.r.l., c/o University of Salerno, Fisciano (SA), Italy
4Department of Medicine and Surgery, University of Salerno, Baronissi, SA, Italy
5Cardiology Division, Massachusetts General Hospital and Harvard Medical School, Boston, USA
6Dipartimento di Scienze Mediche, Orali e Biotecnologiche, CeSI, Universita' 'G. D'Annunzio' di Chieti e Pescara, Pescara, Italy

Tóm tắt

AbstractBcl2-associated athanogene 3 (BAG3), is constitutively expressed in a few normal cell types, including myocytes, peripheral nerves and in the brain, and is also expressed in certain tumors. To date, the main studies about the role of BAG3 are focused on its pro-survival effect in tumors through various mechanisms that vary according to cellular type. Recently, elevated concentrations of a soluble form of BAG3 were described in patients affected by advanced stage of heart failure (HF), identifying BAG3 as a potentially useful biomarker in monitoring HF progression. Despite the finding of high levels of BAG3 in the sera of HF patients, there are no data on its possible role on the modulation of vascular tone and blood pressure levels. The aim of this study was to investigate the possible hemodynamic effects of BAG3 performing both in vitro and in vivo experiments. Through vascular reactivity studies, we demonstrate that BAG3 is capable of evoking dose-dependent vasorelaxation. Of note, BAG3 exerts its vasorelaxant effect on resistance vessels, typically involved in the blood pressure regulation. Our data further show that the molecular mechanism through which BAG3 exerts this effect is the activation of the PI3K/Akt signalling pathway leading to nitric oxide release by endothelial cells. Finally, we show that in vivo BAG3 administration is capable of regulating blood pressure and that this is dependent on eNOS regulation since this ability is lost in eNOS KO animals.

Từ khóa


Tài liệu tham khảo

Takayama S, Xie Z, Reed JC . An evolutionarily conserved family of Hsp70/Hsc70 molecular chaperone regulators. The Journal of biological chemistry 1999; 274: 781–786.

Rosati A, Graziano V, De Laurenzi V, Pascale M, Turco MC . BAG3: a multifaceted protein that regulates major cell pathways. Cell Death Dis 2011; 2: e141.

Fuchs M, Poirier DJ, Seguin SJ, Lambert H, Carra S, Charette SJ et al. Identification of the key structural motifs involved in HspB8/HspB6-Bag3 interaction (vol 425, pg 245, 2010). Biochem J 2010; 430: 559–559.

Chiappetta G, Ammirante M, Basile A, Rosati A, Festa M, Monaco M et al. The antiapoptotic protein BAG3 is expressed in thyroid carcinomas and modulates apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligand. J Clin Endocr Metab 2007; 92: 1159–1163.

De Marco M, Turco MC, Rosati A . BAG3 protein is induced during cardiomyoblast differentiation and modulates myogenin expression. Cell Cycle 2011; 10: 850–852.

Labeit S . BAG3 in heart disease: novel clues for cardiomyocyte survival from the Z-disk? Hum Mutat 2011; 32: iv.

Bruno AP, Festa M, Dal Piaz F, Rosati A, Turco MC, Giuditta A et al. Identification of a synaptosome-associated form of BAG3 protein. Cell Cycle 2008; 7: 3104–3105.

Lee MY, Kim SY, Shin SL, Choi YS, Lee JH, Tsujimoto Y et al. Reactive astrocytes express bis, a Bcl-2-binding protein, after transient forebrain ischemia. Exp Neurol 2002; 175: 338–346.

Franceschelli S, Rosati A, Lerose R, De Nicola S, Turco MC, Pascale M . Bag3 gene expression is regulated by heat shock factor 1. J Cell Physiol 2008; 215: 575–577.

Ammirante M, Rosati A, Arra C, Basile A, Falco A, Festa M et al. IKK{gamma} protein is a target of BAG3 regulatory activity in human tumor growth. Proc Natl Acad Sci 2010; 107: 7497–7502.

Festa M, Del Valle L, Khalili K, Franco R, Scognamiglio G, Graziano V et al. BAG3 protein is overexpressed in human glioblastoma and is a potential target for therapy. Am J Pathol 2011; 178: 2504–2512.

Chiappetta G, Basile A, Arra C, Califano D, Pasquinelli R, Barbieri A et al. BAG3 Down-modulation reduces anaplastic thyroid tumor growth by enhancing proteasome-mediated degradation of BRAF protein. J Clin Endocr Metab 2012; 97: E115–E120.

De Marco M, Falco A, Basile A, Rosati A, Festa M, d'Avenia M et al. Detection of soluble BAG3 and anti-BAG3 antibodies in patients with chronic heart failure. Cell Death Dis 2013; 4: e495.

De Marco M, D'Auria R, Rosati A, Vitulano G, Gigantino A, Citro R et al. BAG3 protein in advanced-stage heart failure. Jacc-Heart Fail 2014; 2: 673–675.

Gandhi PU, Gaggin HK, Belcher AM, Harisiades JE, Basile A, Falco A et al. Analysis of BAG3 plasma concentrations in patients with acutely decompensated heart failure. Clin Chim Acta 2015; 445: 73–78.

Drozdz T, Bilo G, Debicka-Dabrowska D, Klocek M, Malfatto G, Kielbasa G et al. Blood pressure changes in patients with chronic heart failure undergoing slow breathing training. Blood Press 2016; 25: 4–10.

Carrizzo A, Puca A, Damato A, Marino M, Franco E, Pompeo F et al. Resveratrol improves vascular function in patients with hypertension and dyslipidemia by modulating NO metabolism. Hypertension 2013; 62: 359–366.

Nishimatsu H, Suzuki E, Nagata D, Moriyama N, Satonaka H, Walsh K et al. Adrenomedullin induces endothelium-dependent vasorelaxation via the phosphatidylinositol 3-kinase/Akt-dependent pathway in rat aorta. Circ Res 2001; 89: 63–70.

Rosati A, Basile A, D'Auria R, d'Avenia M, De Marco M, Falco A et al. BAG3 promotes pancreatic ductal adenocarcinoma growth by activating stromal macrophages. Nat Commun 2015; 6: 86695.

Iwasaki M, Homma S, Hishiya A, Dolezal SJ, Reed JC, Takayama S . BAG3 regulates motility and adhesion of epithelial cancer cells. Cancer Res 2007; 67: 10252–10259.

Hishiya A, Kitazawa T, Takayama S . BAG3 and Hsc70 interact with actin capping protein CapZ to maintain myofibrillar integrity under mechanical stress. Circ Res 2010; 107: 1220–1231.

Feldman AM, Gordon J, Wang J, Song J, Zhang XQ, Myers VD et al. BAG3 regulates contractility and Ca(2+) homeostasis in adult mouse ventricular myocytes. J Mol Cell Cardiol 2016; 92: 10–20.

d'Avenia M, Citro R, De Marco M, Veronese A, Rosati A, Visone R et al. A novel miR-371a-5p-mediated pathway, leading to BAG3 upregulation in cardiomyocytes in response to epinephrine, is lost in Takotsubo cardiomyopathy. Cell Death Dis 2015; 6: e1948.

Storrow AB, Jenkins CA, Self WH, Alexander PT, Barrett TW, Han JH et al. Reply: BAG3 protein in advanced-stage heart failure. Jacc-Heart Fail 2014; 2: 675–675.

Gruhn N, Larsen FS, Boesgaard S, Knudsen GM, Mortensen SA, Thomsen G et al. Cerebral blood flow in patients with chronic heart failure before and after heart transplantation. Stroke; J cerebral circulation 2001; 32: 2530–2533.

Packer M . Pathophysiology of chronic heart failure. Lancet 1992; 340: 88–92.

Carnevale D, Vecchione C, Mascio G, Esposito G, Cifelli G, Martinello K et al. PI3Kgamma inhibition reduces blood pressure by a vasorelaxant Akt/L-type calcium channel mechanism. Cardiovasc Res 2012; 93: 200–209.